EKF Diagnostics Investor Announcements
EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.
Dividend Timetable
Half-year Report
Notice of Results
Strong double-digit growth in underlying (non-COVID) revenue
TR-1: Standard form for notification of major holdings
Purchase of shares in EKF Diagnostics Holdings plc.
Approval of dividend in specie of investment in Verici Dx plc
EKF Diagnostics provides an update following the strengthening of its cash position.
Enabling hospitals, labs and GPs to manage and evaluate patient data easily and securely
EKF announces the completion of the Company’s buyback programme
Archive
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
Mount Sinai investments related
RNS announcements
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.